GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (GREY:XLSCF) » Definitions » Gross-Profit-to-Asset %

Xlife Sciences AG (Xlife Sciences AG) Gross-Profit-to-Asset % : 0.13% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Xlife Sciences AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Xlife Sciences AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was $0.75 Mil. Xlife Sciences AG's average Total Assets over the quarter that ended in Dec. 2023 was $561.42 Mil. Therefore, Xlife Sciences AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.13%.

Xlife Sciences AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Xlife Sciences AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG Gross-Profit-to-Asset % Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 0.12 -0.02 0.11 0.04 0.09

Xlife Sciences AG Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 - 0.08 0.05 0.13

Competitive Comparison of Xlife Sciences AG's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Xlife Sciences AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xlife Sciences AG's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's Gross-Profit-to-Asset % falls into.


Xlife Sciences AG Gross-Profit-to-Asset % Calculation

Xlife Sciences AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.519/( (526.224+592.037)/ 2 )
=0.519/559.1305
=0.09 %

Xlife Sciences AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.754/( (530.81+592.037)/ 2 )
=0.754/561.4235
=0.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Xlife Sciences AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG (Xlife Sciences AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (GREY:XLSCF) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
XSWX:IDIA XSWX:SANN XSWX:MOLN XSWX:NWRN XSWX:RLF XSWX:EVE XSWX:SPEX XSWX:BSLN XSWX:OBSN XSWX:ADXN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
XLS:Switzerland
Address
Talacker 35, Zürich, CHE, 8001
Website
https://www.xlifesciences.ch
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (Xlife Sciences AG) Headlines

From GuruFocus

Xlife Sciences AG Plans Listing on the 'Sparks' Segment of SIX Swiss Exchange

By ACCESSWIRE ACCESSWIRE • 01-10-2022

Xlife Sciences AG: curasan AG and Xlife Sciences AG Cooperate in the Field of Regenerative Medicine

By ACCESSWIRE ACCESSWIRE • 06-16-2021

Xlife Sciences AG: Xlife Sciences AG is Elected as Innovation Partner for Saudi Arabia

By ACCESSWIRE ACCESSWIRE • 10-26-2021

Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH

By ACCESSWIRE ACCESSWIRE • 10-07-2021

Xlife Sciences AG: Breakthrough in Drug Development

By ACCESSWIRE ACCESSWIRE • 06-10-2021